Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments

The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.

Saved in:
Bibliographic Details
Main Authors Kraemer, Gerd, Martin, Hans-Juergen, Adelgoss, Gebhard, Dugi, Klaus, Duran, Adil, Eickelmann, Peter, Maier, Steffen, Pinnetti, Sabine, Ritter, Regine, Schilcher, Gebhard, Streicher, Ruediger, Thomas, Leo
Format Patent
LanguageEnglish
Published 28.04.2009
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.